|
Session 98
Poster Abstracts
Clinical Pharmacology of Other Drug Classes
Tuesday, 1:30 - 3:30 pm
Poster Hall |
579
 |
Unexpected Drug-Drug Interaction between Tipranavir/Ritonavir and Enfuvirtide
D Gonzalez De Requena, Andrea Calcagno*, S Bonora, L Ladetto, A D'Avolio, M Sciandra, M Siccardi, O Bargiacchi, A Sinicco, and G Di Perri
Univ of Turin, Italy |
580
|
Safety and Pharmacokinetics of Single Oral Dose of JTK-303/GS 9137, a Novel HIV Integrase Inhibitor, in Healthy Volunteers
Isao Kawaguchi*1, T Ishikawa1, M Ishibashi2, S Irie2, and A Kakee1
1Japan Tobacco, Tokyo and 2Kyushu Clin Pharma Res Clin, Fukuoka, Japan |
| 581 |
Ribavirin Plasma Levels throughout the Course of HCV Therapy in HCV/HIV-co-infected Patients: Clinical Implications
Ana Rendón*, M Nuñez, M Romero, P Barreiro, L Martín-Carbonero, J García-Samaniego, I Jiménez-Nácher, J González-Lahoz, and V Soriano
Hosp Carlos III, Madrid, Spain |
| 582 |
Pharmacokinetics of Vicriviroc are not Affected in Combination with Five Different Protease Inhibitors Boosted by Ritonavir
Angela Sansone*, A Keung, E Tetteh, H Weisbrot, M Martinho, S Lang, R Keller, and M Kraan
Schering-Plough Res Inst, Kenilworth, NJ, US |
|
